EDGAR Filing Documents for 0001181431-11-053927

Form 8-K - Current report:

SEC Accession No. 0001181431-11-053927

Filing Date

2011-10-31

Accepted

2011-10-31 14:49:13

Documents

Period of Report

2011-10-27

Items

Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	rrd324623.htm	8-K	16046
2	PRESS RELEASE, DATED OCTOBER 27, 2011, TITLED "DYNAVAX REPORTS THIRD QUARTER 201	rrd324623_36312.htm	EX-99	56422
3	PRESS RELEASE, DATED OCTOBER 27, 2011, TITLED "DYNAVAX PHASE 3 DATA IN CHRONIC K	rrd324623_36313.htm	EX-99	9118
4	PRESS RELEASE, DATED OCTOBER 27, 2011, TITLED "DYNAVAX CONFIRMS HEPLISAV(TM) SUB	rrd324623_36314.htm	EX-99	6376
	Complete submission text file	0001181431-11-053927.txt		89129

Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710

Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100

DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)